US 10071101
Use of cinnabarinic acid as a modulator of immune response in autoimmune disorders
granted A61KA61K31/538A61P
Quick answer
US patent 10071101 (Use of cinnabarinic acid as a modulator of immune response in autoimmune disorders) held by The Regents of the University of California expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/538, A61P, A61P1/16, A61P17/00